Follow
Vibhavari Sail
Vibhavari Sail
Verified email at omrf.org
Title
Cited by
Cited by
Year
Repurposing the clinically efficacious antifungal agent itraconazole as an anticancer chemotherapeutic
JR Pace, AM DeBerardinis, V Sail, SK Tacheva-Grigorova, KA Chan, ...
Journal of medicinal chemistry 59 (8), 3635-3649, 2016
652016
Intestinal lineage commitment of embryonic stem cells
L Cao, JD Gibson, S Miyamoto, V Sail, R Verma, DW Rosenberg, ...
Differentiation 81 (1), 1-10, 2011
622011
Identification of small molecule translesion synthesis inhibitors that target the Rev1-CT/RIR protein− protein interaction
V Sail, AA Rizzo, N Chatterjee, RC Dash, Z Ozen, GC Walker, ...
ACS chemical biology 12 (7), 1903-1912, 2017
562017
Structure–activity relationships for vitamin D3-based aromatic A-ring analogues as Hedgehog pathway inhibitors
AM DeBerardinis, DJ Madden, U Banerjee, V Sail, DS Raccuia, ...
Journal of Medicinal Chemistry 57 (9), 3724-3736, 2014
332014
Notch pathway modulators as anticancer chemotherapeutics
V Sail, MK Hadden
Annual reports in medicinal chemistry 47, 267-280, 2012
192012
Identification of small molecule Hes1 modulators as potential anticancer chemotherapeutics
V Sail, MK Hadden
Chemical Biology & Drug Design 81 (3), 334-342, 2013
102013
Probing seco-steroid inhibition of the hedgehog signaling pathway
EN Thompson, V Sail, DS Raccuia, MK Hadden
Molecular and Cellular Biochemistry 450, 75-85, 2019
22019
AB-2100, a PSMA-inducible CA9-specific CAR T cell product for the treatment of ccRCC provides long-term tumor responses in preclinical mouse model
S Mohanty, J Chen, A Gomez, A Boroughs, I Scarfo, L Lim, K Dang, ...
Cancer Research 84 (6_Supplement), 38-38, 2024
2024
Characterization of AB-1015 logic-gated CAR induction (ON kinetics), receptor turnover (OFF kinetics), and logic gate sensitivity to ALPG/P and MSLN
X Tang, M Chew, R Sudhakar, H Yun, D Sakamoto, V Sail, A Fearon, ...
Cancer Research 84 (6_Supplement), 6319-6319, 2024
2024
Enhancing TCR T cell function in solid tumors through in vivo combinatorial screens and single-cell analysis
D Polyak, J Fuhriman, J Susanto, A Merrell, M Simon, C Oh, A Cordazo, ...
Cancer Research 84 (6_Supplement), 7042-7042, 2024
2024
Pooled CRISPR screening coupled with single-cell sequencing identifies modifiers of CAR T cell state in the context of chronic antigen stimulation
S Joshi, G Wozniak, J Gagnon, K Vucci, A Merrell, M Simon, C Oh, ...
Cancer Research 84 (6_Supplement), 7034-7034, 2024
2024
Development of AB-2100, an autologous integrated circuit T (ICT) cell therapy targeting CA9 intended for the treatment of ccRCC.
M Landon, I Scarfo, M Chew, R Sudhakah, M Nguyen, S Mohanty, J Chen, ...
Journal of Clinical Oncology 42 (4_suppl), 472-472, 2024
2024
301 Preclinical development of AB-2100, a PSMA neovasculature-inducible CA9 CAR resistant to FASL and TGFb mediated suppression for the treatment of ccRCC
I Scarfo, L Lim, K Dang, M Chew, R Sudhakah, M Nguyen, S Mohanty, ...
Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023
2023
A neovasculature-inducible CA9 CAR resistant to FASL and TGFb mediated suppression for the treatment of ccRCC
AC Boroughs, I Scarfo, N Attanasio, T Gardner, JB Smith, J McDevitt, ...
Cancer Research 83 (7_Supplement), 4088-4088, 2023
2023
Identification of small molecule translesion synthesis inhibitors that target Rev1 protein-protein interactions
M Hadden, V Sail, E Thompson, A Rizzo, D Korzhnev
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 251, 2016
2016
The system can't perform the operation now. Try again later.
Articles 1–15